CytoDyn Inc.
Balance Sheet
| Line Item | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||
| Cash & Equivalents | $11.9M | $11.9M | $3.1M | $2.5M | $4.2M | $33.9M | $14.3M | $2.6M |
| Accounts Receivable | — | — | — | — | — | — | — | — |
| Inventory | — | — | $0 | $0 | — | $93.5M | $19.1M | — |
| Total Current Assets | $13.9M | $17.9M | $10.8M | $10.8M | $10.5M | $36.1M | $36.8M | $5.4M |
| Property, Plant & Equipment | — | — | — | — | $73.0K | $134.0K | $55.0K | $29.3K |
| Goodwill | — | — | — | — | — | — | — | — |
| Intangible Assets (Excl. Goodwill) | — | — | — | — | $132.0K | $1.7M | $13.5M | $15.5M |
| Total Assets | $14.0M | $18.0M | $11.1M | $11.3M | $29.2M | $132.1M | $50.5M | $20.9M |
| Liabilities | ||||||||
| Accounts Payable | $13.2M | $14.7M | $29.6M | $62.7M | $68.0M | $65.9M | $29.5M | $16.2M |
| Total Current Liabilities | $53.7M | $70.5M | $84.2M | $119.8M | $123.2M | $152.5M | $44.5M | $26.9M |
| Long-Term Debt | $38.3M | $45.4M | $45.0M | $45.7M | $42.2M | $64.8M | — | — |
| Total Liabilities | $123.7M | $114.1M | $127.9M | $120.8M | $123.6M | $153.1M | $53.0M | $29.8M |
| Stockholders' Equity | ||||||||
| Retained Earnings | $-930.5M | $-887.8M | $-891.5M | $-841.7M | $-766.1M | $-639.9M | $-445.2M | $-229.4M |
| Total Stockholders' Equity | $-109.7M | $-96.0M | $-116.8M | $-109.5M | $-94.4M | $-21.0M | $-2.5M | $-8.9M |